Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients.

Yoo, Il Han; Kim, WooJoong; Kim, Hunmin; Lim, Byung Chan; Hwang, Hee; Chae, Jong Hee; Choi, Jieun; Kim, Ki Joong

Yoo, Il Han; Kim, WooJoong; Kim, Hunmin; Lim, Byung Chan; Hwang, Hee; Chae, Jong Hee; Choi, Jieun; Kim, Ki Joong.

Afiliação

Yoo IH; Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim W; Department of Pediatrics, St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Suwon, Korea.
Kim H; Pediatric Clinical Neuroscience Center, Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Lim BC; Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea. 65714@snubh.org.
Hwang H; Pediatric Clinical Neuroscience Center, Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Chae JH; Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.
Choi J; Pediatric Clinical Neuroscience Center, Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Kim KJ; Department of Pediatrics, SMG-SNU Boramae Medical Center, Seoul, Korea.

J Clin Neurol ; 13(3): 281-286, 2017 Jul.

Article em En | MEDLINE | ID: mdl-28748680

Palavras-chave

migraine; predictive factor; prophylaxis; topiramate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google